Searched over 200M research papers
10 papers analyzed
These studies suggest that home blood glucose monitoring can improve diabetic control, reduce complications, and is generally preferred over urine testing, though accuracy and effectiveness can vary.
19 papers analyzed
Recent advancements in at-home diabetes testing have shown promising results in predicting the risk of Type 1 Diabetes (T1D) using continuous glucose monitoring (CGM). A study involving 60 healthy relatives of T1D patients utilized a one-week CGM home test to monitor glycemic differences based on autoantibody presence. The study found significant differences in glycemia metrics such as percent time >180 mg/dL (T180) weekly, overnight CGM incremental AUC, and T180 for 75 minutes post-standardized liquid mixed meal (SLMM) CGM traces. Incorporating these features into machine-learning classifiers, the study achieved an AUC-ROC of ≥0.81, indicating a high performance in classifying antibody-positive versus antibody-negative participants. This suggests that a self-administered one-week CGM home test, combined with machine learning, can significantly improve T1D risk detection without the need for hospital visits.
Home blood-glucose monitoring (HBGM) has been shown to significantly improve blood-glucose control in diabetic patients. In a study with 64 diabetic patients using Dextrostix and Eyetone meters, 64% of participants maintained good control of their blood-glucose levels for extended periods. This method allowed for easier and more predictable adjustments of insulin dosage compared to urine-glucose analysis, leading to fewer hypoglycemic episodes and a preference for blood tests over urine tests among patients. Another study highlighted that HBGM led to improved diabetic control and lifestyle, reducing the frequency of hospital admissions and demonstrating a high patient acceptance rate.
A study comparing blood and urine testing in newly diagnosed non-insulin dependent diabetes patients found that blood testing was more effective. Patients who participated in a structured group education program showed better control and understanding of their condition when using blood tests compared to urine tests. Additionally, another study indicated that home blood sampling for plasma glucose assays provided sufficiently precise measurements, which could help prevent diabetic complications by improving control over basal plasma glucose concentrations.
The accuracy of home glucose meters (HGMs) in detecting hypoglycemia has been a concern. A study evaluating five different HGMs found that not all devices were accurate enough to sense low blood glucose levels. The Accu-Chek Go, Optium Xceed, and Contour TS meters performed better than others, but the study emphasized the need for patients and caregivers to be aware of the limitations of HGMs and to consider hypoglycemia symptoms over meter readings.
Patients generally prefer blood glucose monitoring over urine tests due to its accuracy and ease of use. A historical review at St. Thomas' Hospital in London showed that patients, including children, overwhelmingly preferred blood glucose monitoring, which led to better control and fewer hypoglycemic attacks. The introduction of user-friendly devices like Glucochek further enhanced patient compliance and satisfaction. However, a cross-sectional study on non-insulin treated diabetic patients revealed that while home glucose monitoring is widely practiced, its effectiveness in improving blood glucose control or preventing complications remains inconclusive.
At-home diabetes testing, particularly through continuous glucose monitoring and home blood-glucose monitoring, has shown significant potential in improving diabetic control and predicting diabetes risk. While blood testing is generally preferred over urine testing for its accuracy, the effectiveness of home glucose monitoring in non-insulin treated patients requires further investigation. The accuracy of home glucose meters in detecting hypoglycemia remains a critical area for improvement. Overall, advancements in at-home diabetes testing technologies continue to enhance patient management and outcomes.
Most relevant research papers on this topic